Previous Phase 1b clinical data suggest niclosamide delivers favorable efficacy compared to topical corticosteroid in the treatment of ulcerative proctitis and ulcerative proctosigmoiditis BOCA RATON, ...
BEVERLY, Mass., March 16, 2017 (GLOBE NEWSWIRE) -- Cellceutix Corporation, (OTCQB:CTIX) (“the Company”), a clinical stage biopharmaceutical company developing innovative therapies with dermatology, ...
Markets Insider and Business Insider Editorial Teams were not involved in the creation of this post. Indices Commodities Currencies Stocks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results